Guang-Xin Xu

Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling

Changgeng Qian, Cheng-Jung Lai, Rudi Bao et al. · Clinical Cancer Research · 2012 · 241 citations

Medicine, Oncology, Pharmacology +15

CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity

Cheng-Jung Lai, Rudi Bao, Xu Tao et al. · Cancer Research · 2010 · 212 citations · Full text

Medicine, Oncology, Pharmacology +17

Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers

Kaiming Sun, Ruzanna Atoyan, Mylissa Borek et al. · Molecular Cancer Therapeutics · 2016 · 147 citations

Medicine, Cancer Biology, Oncology +16

Modulation of Hair Growth with Small Molecule Agonists of the Hedgehog Signaling Pathway

Rudolph D. Paladini, Jacqueline Saleh, Changgeng Qian et al. · Journal of Investigative Dermatology · 2005 · 130 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +16

CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy

Rudi Bao, Cheng-Jung Lai, Hui Qu et al. · Clinical Cancer Research · 2009 · 112 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10